Lloyd W. Helms Jr - May 23, 2022 Form 4 Insider Report for EOG RESOURCES INC (EOG)

Signature
Vicky Strom, attorney-in-fact for Lloyd W. Helms, Jr.
Stock symbol
EOG
Transactions as of
May 23, 2022
Transactions value $
-$252,932
Form type
4
Date filed
5/24/2022, 03:45 PM
Previous filing
May 2, 2022
Next filing
Jul 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOG Common Stock Options Exercise $934K +9.83K +7.1% $95.05 148K May 23, 2022 Direct
transaction EOG Common Stock Disposed to Issuer -$934K -7.38K -4.98% $126.62 141K May 23, 2022 Direct
transaction EOG Common Stock Tax liability -$122K -964 -0.68% $126.62 140K May 23, 2022 Direct
transaction EOG Common Stock Options Exercise $1.05M +11K +7.83% $96.29 151K May 23, 2022 Direct
transaction EOG Common Stock Disposed to Issuer -$1.05M -8.33K -5.52% $126.62 143K May 23, 2022 Direct
transaction EOG Common Stock Tax liability -$131K -1.03K -0.72% $126.62 141K May 23, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EOG Stock Appreciation Rights Options Exercise $0 -9.83K -100% $0.00* 0 May 23, 2022 Common Stock 9.83K $95.05 Direct F1
transaction EOG Stock Appreciation Rights Options Exercise $0 -11K -100% $0.00* 0 May 23, 2022 Common Stock 11K $96.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The SARs granted became exercisable in 25% increments beginning one year from the September 29, 2016 date of grant and on each of the next three grant date anniversaries. The SARs granted became fully exercisable on September 29, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F2 The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock.